Login
Search
Search
0 Dates
2026
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
CPC 2026
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
The clinical importance of the Metabolic Score for Insulin Resistance (METS-IR) in assessing insulin resistance and its association with arterial stiffness
Session:
Sessão de Comunicações Orais 05 – Para além do LDL: determinantes metabólicos do risco cardiovascular
Speaker:
Carolina Mendonça de Olim
Congress:
CPC 2026
Topic:
J. Preventive Cardiology
Theme:
28. Risk Factors and Prevention
Subtheme:
28.14 Risk Factors and Prevention - Other
Session Type:
Comunicações Orais
FP Number:
---
Authors:
Carolina Olim; Ana Célia Sousa; Cláudia Sousa; Cátia Martins; Vasco Nunes; Carolina Freitas; Mariana Rodrigues; Ana Cardoso; Sofia Borges; Maria João Oliveira; Maria Isabel Mendonça; Roberto Palma Dos Reis
Abstract
<p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:"Times New Roman","serif""><strong><span style="font-size:11.0pt"><span style="font-family:"Calibri","sans-serif"">Introduction:</span></span></strong><span style="font-size:11.0pt"><span style="font-family:"Calibri","sans-serif""> Arterial stiffness increases due to biological aging and arteriosclerosis, progressively reducing vessel elasticity and contributing to endothelial dysfunction and cardiovascular risk. Both genetic and behavioral factors accelerate vascular deterioration. Insulin resistance (IR) is a major cardiometabolic risk marker; however, its association with arterial stiffness assessed by pulse wave velocity (PWV) is not well established.</span></span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:"Times New Roman","serif""><strong><span style="font-size:11.0pt"><span style="font-family:"Calibri","sans-serif"">Objective:</span></span></strong><span style="font-size:11.0pt"><span style="font-family:"Calibri","sans-serif""> Evaluate whether IR, assessed by the metabolic score for insulin resistance (METS-IR), is associated with PWV and whether a correlation exists between these variables.</span></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,"sans-serif""><strong><span style="font-family:"Calibri","sans-serif"">Methods:</span></strong> In 882 individuals (mean age 50.5±8.7 years), the Carotid–femoral PWV was determined using the Complior device, and METS-IR was calculated:<br /> <span style="background-color:white">ln[2×fasting blood glucose (FBG) + triglycerides (TG)]×body mass index (BMI) / ln [ </span>High Density Lipoprotein<span style="background-color:white">-Cholesterol (HDL-C) <span style="font-family:"Calibri","sans-serif"">]</span>.</span> Participants were categorized as cases (PWV ≥10 m/s) or controls (PWV <10 m/s), and METS-IR values were divided into quartiles. METS-IR values were divided into four quartiles: 1st ≤35.17; 2nd >35.17 and ≤40.62; 3rd >40.62 and ≤47.17; and 4th >47.17. In both PWV groups, the percentage of individuals was evaluated in the 1st and 4th METS-IR quartilhes. A Pearson correlation was subsequently performed between PWV and METS-IR values. Finally, a multivariable analysis was conducted including other cardiovascular risk factors (physical inactivity, alcohol consumption, and smoking) together with METS-IR, to determine which variables were significantly and independently associated with increased PWV.</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,"sans-serif""><strong><span style="font-family:"Calibri","sans-serif"">Results:</span></strong> 89 participants (10.1%) had PWV ≥10 m/s, while 793 (89.9%) were controls. High PWV showed a greater proportion of individuals in the 4th METS-IR quartile (62.9%) versus the 1st quartile (37.1%), while controls showed the opposite pattern (48.5% vs. 51.5%) (p=0.010). A positive correlation was observed between PWV and METS-IR (p<0.0001). In multivariable analysis, METS-IR remained independently associated with elevated PWV (OR=1.616; 95%CI: 1.018–2.567; p=0.042), together with physical inactivity (OR=1.696; 95%CI: 1.053–2.734; p=0.030).</span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:"Times New Roman","serif""><strong><span style="font-size:11.0pt"><span style="font-family:"Calibri","sans-serif"">Conclusions:</span></span></strong><span style="font-size:11.0pt"><span style="font-family:"Calibri","sans-serif""> METS-IR is significantly and independently associated with increased arterial stiffness in this population. The positive correlation between METS-IR and PWV reinforces the role of insulin resistance in arterial wall damage and arterial stiffening. METS-IR may serve as a practical and scalable tool in clinical practice for early vascular risk assessment. </span></span></span></span></p>
Our mission: To reduce the burden of cardiovascular disease
Visit our site